TAG:
hospital laboratories
“Lowest-Priced” Chickens Came Home to Roost
By R. Lewis Dark | From the Volume XII No. 4 – March 7, 2005 Issue
IN READING THE INTELLIGENCE BRIEFINGS on reference/esoteric laboratories in this issue, I found it interesting that American Medical Laboratories (AML) is no longer an independent lab company serving this market segment and that, of the four remaining independent lab companies focuse…
FL Medicaid Gives Up On Statewide Lab Contract
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: With the withdrawal of the December 13, 2004 “Invitation to Negotiate” (ITN), Florida’s Medicaid bureaucrats seem to have thrown in the towel—at least for the moment—on the effort to give a single laboratory company an exclusive three-year contract to provide labora…
Profit Squeeze Pressures Specialty Laboratories
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Despite much success and milestones at Specialty Laboratories during the past 36 months, it has yet to achieve the most important goal of all: net profits. One reason is familiar to all laboratory administrators and pathologists: with its existing fixed overhead and cost stru…
National Reference Labs Undergoing Changes
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Maybe it’s a coincidence. More likely it is a response to changes in the reference/esoteric marketplace. Specialty, Esoterix, ARUP, and Mayo have each recently reassessed their core strategies and are shifting their business emphasis. Because three of these four companies a…
Baylor University Lab Serves ED Needs With STAT Lab
By Robert Michel | From the Volume XII No. 4 – March 7, 2005 Issue
CEO SUMMARY: Throughout the United States, hospital laboratories are working to meet ever-increasing lab testing demands by emergency department physicians. In response, many labs debate the benefits of a point-of-care testing (POCT) solution versus operating a rapid response lab in or ne…
Bi-Annual Look at Trends Reshaping Clinical Labs
By Robert Michel | From the Volume XII No. 2 – January 24, 2005 Issue
CEO SUMMARY: Among other things, we declare the end to the heyday of the independent commercial lab company which offers a broad test menu to all types of office-based physicians. In its place springs forth the specialty or niche testing laboratory. Small and focused on a specific number …
Change Beneath Surface Marks 2004 Lab Stories
By Robert Michel | From the Volume XI No. 17 – December 13, 2004 Issue
CEO SUMMARY: Presented here are THE DARK REPORT’S “Ten Biggest Lab Stories of 2004.” These are the events we consider most important to the lab industry during the year. However, in contrast to past years, 2004 lacked the types of blockbuster events which radically change and reshap…
Aureon Biosciences, Bayer, Competitive Technologies, Rare Blood Infections, Kaiser Permanente
By Robert Michel | From the Volume XI No. 16 – November 22, 2004 Issue
KEVIN JOHNSON AND VIJAY AGGARWAL JOIN AUREON BIOSCIENCES TWO VETERAN LAB EXECUTIVES are back in the business. Kevin Johnson is now the Chairman at Aureon Biosciences Corporation and Vijay Aggarwal, Ph.D. is President and CEO. The fact that both men chose to join Aureon Bios…
“November 1, 2004 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume XI No. 15 – November 1, 2004 Issue
At a steady rate, healthcare is evolving toward a fully-electronic, Internet-based informatics environment. Here are some noteworthy mile-stones that illustrate this progress. During 2003, consumers’ use of the Web to access their health insurers’ Web sites increased 94%! So reports the Manhattan…
Homocysteine Patent Triggers Royalty Demand
By Robert Michel | From the Volume XI No. 15 – November 1, 2004 Issue
CEO SUMMARY: Laboratory Corporation of America fought a patent infringement case against the holder of the homocysteine assay patent and lost after a five-year court battle. Now Competitive Technologies, Inc. (CTI), armed with its victory in federal court, is ready to negotiate royalty ar…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized